We are live on !
Find out more
HoyleCohen Portfolio holdings
AUM
$1.32B
Turnover
16.17%
1-Year Est. Return
27.05%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$11.2M
(+0.85%)
Cap. Flow
-$55.8M
Cap. Flow % of AUM
Cap. Flow %
-4.22%
Top 10 Holdings %
Top 10 Hldgs %
34.61%
Holding
303
New
21
Increased
57
Reduced
164
Closed
28
Avg Time Held
4.2
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$4.58M |
| 2 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$2.41M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$2.21M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.31M |
| 5 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$819K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$6.37M |
| 2 |
Apple
AAPL
|
+$4.94M |
| 3 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$4.57M |
| 4 |
JPMorgan USD Emerging Markets Sovereign Bond ETF
JPMB
|
+$3.61M |
| 5 |
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
|
+$2.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Miscellaneous | 25.25% |
| 3 | Financials | 10.45% |
| 4 | Healthcare | 7.17% |
| 5 | Communication Services | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Vanguard Morningstar Large-Cap ETF
VV
$54.6B
| $235K | 0.02% |
941
-67
| -7% | -$16.1K |
2024 Q1
1 quarter
|
|
252
Emerson Electric
EMR
$91.3B
| $235K | 0.02% |
2,129
-33
| -2% | -$3.65K |
2024 Q1
1 quarter
|
|
253
Duke Energy
DUK
$97.1B
| $230K | 0.02% |
2,296
-877
| -28% | -$87.7K |
2020 Q3
15 quarters
|
|
254
iShares S&P Small-Cap 600 Value ETF
IJS
$7.67B
| $230K | 0.02% |
2,360
| – | – |
2023 Q2
4 quarters
|
|
255
Amplify CEF High Income ETF
YYY
$655M
| $226K | 0.02% |
+18,800
| New | +$224K |
2024 Q2
0 quarters
|
|
256
Church & Dwight Co
CHD
$24.9B
| $226K | 0.02% |
2,177
+75
| +4% | +$7.93K |
2024 Q1
1 quarter
|
|
257
AstraZeneca
AZN
$266B
| $224K | 0.02% |
+1,438
| New | +$216K |
2024 Q2
0 quarters
|
|
258
PNC Financial Services
PNC
$90B
| $223K | 0.02% |
1,431
+2
| +0.1% | +$310 |
2023 Q4
2 quarters
|
|
259
Regeneron Pharmaceuticals
REGN
$83.7B
| $222K | 0.02% |
+211
| New | +$205K |
2024 Q2
0 quarters
|
|
260
Schwab US Aggregate Bond ETF
SCHZ
$10.8B
| $213K | 0.02% |
9,358
-54
| -0.6% | -$1.22K |
2017 Q4
26 quarters
|
|
261
Halozyme
HALO
$14.5B
| $209K | 0.02% |
+4,000
| New | +$175K |
2024 Q2
0 quarters
|
|
262
iShares Select Dividend ETF
DVY
$23.4B
| $205K | 0.02% |
1,698
-38
| -2% | -$4.61K |
2023 Q4
2 quarters
|
|
263
Equinix
EQIX
$97.9B
| $204K | 0.02% |
270
-51
| -16% | -$38.7K |
2020 Q4
14 quarters
|
|
264
Anfield Universal Fixed Income ETF
AFIF
$224M
| $201K | 0.02% |
+22,046
| New | +$201K |
2024 Q2
0 quarters
|
|
265
Western Asset Emerging Markets Debt Fund
EMD
$528M
| $172K | 0.01% |
+18,500
| New | +$172K |
2024 Q2
0 quarters
|
|
266
DELISTED
Infinera Corporation Common Stock
INFN
| $164K | 0.01% |
27,000
| – | – |
2022 Q1
9 quarters
|
|
|
IGR
267
CBRE Global Real Estate Income Fund
IGR
$548M
| $151K | 0.01% |
10,000
+6,667
| +200% | +$101K |
2024 Q1
1 quarter
|
|
268
Gabelli Convertible and Income Securities Fund
GCV
$79.2M
| $128K | 0.01% |
+35,000
| New | +$126K |
2024 Q2
0 quarters
|
|
269
Ford
F
$46.9B
| $126K | 0.01% |
+10,028
| New | +$124K |
2024 Q2
0 quarters
|
|
270
Mobile Infrastructure Corp
BEEP
$104M
| $65.5K | 0.01% |
+19,110
| New | +$67.4K |
2024 Q2
0 quarters
|
|
271
Editas Medicine
EDIT
$382M
| $55.3K | ﹤0.01% |
+11,834
| New | +$66.8K |
2024 Q2
0 quarters
|
|
272
Standard BioTools
LAB
$243M
| $23K | ﹤0.01% |
13,002
| – | – |
2024 Q1
1 quarter
|
|
273
Personalis
PSNL
$1.72B
| $18K | ﹤0.01% |
15,373
| – | – |
2020 Q1
17 quarters
|
|
274
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $7.61K | ﹤0.01% |
14,000
| – | – |
2021 Q1
13 quarters
|
|
275
DELISTED
Akoustis Technologies Inc
AKTS
| $4.68K | ﹤0.01% |
35,502
-1,000
| -3% | -$377 |
2019 Q4
18 quarters
|
|
Similar funds
HIG
CDH
HoyleCohen's Q2 2024 Portfolio in Review
As of Q2 2024, HoyleCohen held 303 positions worth $1.32B, up 0.85% from $1.31B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
HoyleCohen withdrew a net $55.8M in Q2 2024, closing 28 positions and reducing 164 holdings. Its most notable exit was JPMorgan USD Emerging Markets Sovereign Bond ETF, an estimated $3.61M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, HoyleCohen opened a new position in Vanguard Intermediate-Term Corporate Bond ETF worth $4.61M.
- HoyleCohen's largest Q2 2024 buy was Vanguard Intermediate-Term Corporate Bond ETF: 57,735 shares worth $4.61M.
- HoyleCohen added most to JPMorgan Equity Premium Income ETF in Q2 2024, an estimated $819K increase.
- HoyleCohen's biggest Q2 2024 reduction was Verizon, cutting an estimated $6.37M.
- HoyleCohen fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q2 2024, selling an estimated $3.61M.
- HoyleCohen's ten largest holdings make up 35% of its $1.32B portfolio in Q2 2024.
- HoyleCohen opened 21 new positions and closed 28 in Q2 2024.
- HoyleCohen's portfolio value rose 0.85% quarter-over-quarter to $1.32B.
Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.